Literature DB >> 26365184

TNF Counterbalances the Emergence of M2 Tumor Macrophages.

Franz Kratochvill1, Geoffrey Neale2, Jessica M Haverkamp1, Lee-Ann Van de Velde1, Amber M Smith1, Daisuke Kawauchi3, Justina McEvoy4, Martine F Roussel3, Michael A Dyer4, Joseph E Qualls5, Peter J Murray6.   

Abstract

Cancer can involve non-resolving, persistent inflammation where varying numbers of tumor-associated macrophages (TAMs) infiltrate and adopt different activation states between anti-tumor M1 and pro-tumor M2 phenotypes. Here, we resolve a cascade causing differential macrophage phenotypes in the tumor microenvironment. Reduction in TNF mRNA production or loss of type I TNF receptor signaling resulted in a striking pattern of enhanced M2 mRNA expression. M2 gene expression was driven in part by IL-13 from eosinophils co-recruited with inflammatory monocytes, a pathway that was suppressed by TNF. Our data define regulatory nodes within the tumor microenvironment that balance M1 and M2 populations. Our results show macrophage polarization in cancer is dynamic and dependent on the balance between TNF and IL-13, thus providing a strategy for manipulating TAMs.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365184      PMCID: PMC4581986          DOI: 10.1016/j.celrep.2015.08.033

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  65 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.

Authors:  Francis H W Shand; Satoshi Ueha; Mikiya Otsuji; Suang Suang Koid; Shigeyuki Shichino; Tatsuya Tsukui; Mizuha Kosugi-Kanaya; Jun Abe; Michio Tomura; James Ziogas; Kouji Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-13       Impact factor: 11.205

4.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 5.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

6.  Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.

Authors:  Jessica M Haverkamp; Amber M Smith; Ricardo Weinlich; Christopher P Dillon; Joseph E Qualls; Geoffrey Neale; Brian Koss; Young Kim; Vincenzo Bronte; Marco J Herold; Douglas R Green; Joseph T Opferman; Peter J Murray
Journal:  Immunity       Date:  2014-12-11       Impact factor: 31.745

7.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

8.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages.

Authors:  Jeb S Orr; Michael J Puglisi; Kate L J Ellacott; Carey N Lumeng; David H Wasserman; Alyssa H Hasty
Journal:  Diabetes       Date:  2012-06-29       Impact factor: 9.461

10.  Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity.

Authors:  Hong-Erh Liang; R Lee Reinhardt; Jennifer K Bando; Brandon M Sullivan; I-Cheng Ho; Richard M Locksley
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

View more
  76 in total

1.  New insights into the multidimensional concept of macrophage ontogeny, activation and function.

Authors:  Florent Ginhoux; Joachim L Schultze; Peter J Murray; Jordi Ochando; Subhra K Biswas
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

3.  In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.

Authors:  Abner A Murray; Chao Wang; Steven Fiering; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-25       Impact factor: 4.939

4.  Overexpression of the C-domain of angiotensin-converting enzyme reduces melanoma growth by stimulating M1 macrophage polarization.

Authors:  Zakir Khan; Duo-Yao Cao; Jorge F Giani; Ellen A Bernstein; Luciana C Veiras; Sebastien Fuchs; Yizhou Wang; Zhenzi Peng; Markus Kalkum; George Y Liu; Kenneth E Bernstein
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

5.  Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.

Authors:  Manisha Kumari; Mahaveer P Purohit; Richa Pahuja; Satyakam Patnaik; Yogeshwer Shukla; Pradeep Kumar; Kailash C Gupta
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

6.  The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis.

Authors:  Geou-Yarh Liou; Ligia Bastea; Alicia Fleming; Heike Döppler; Brandy H Edenfield; David W Dawson; Lizhi Zhang; Nabeel Bardeesy; Peter Storz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

Review 7.  Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas-Implications for Therapy.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

Review 8.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

9.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

Authors:  Ilaria Marigo; Serena Zilio; Giacomo Desantis; Bernhard Mlecnik; Andrielly H R Agnellini; Stefano Ugel; Maria Stella Sasso; Joseph E Qualls; Franz Kratochvill; Paola Zanovello; Barbara Molon; Carola H Ries; Valeria Runza; Sabine Hoves; Amélie M Bilocq; Gabriela Bindea; Emilia M C Mazza; Silvio Bicciato; Jérôme Galon; Peter J Murray; Vincenzo Bronte
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

10.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.